References
- Aiyedum, B. A., Williamson, J. & Amodu, A. A. (1973). The effect of Cordycepin on tsetse-borne Trypanosoma vivax infections. Acta Tropica, 30, 276–278.
- Bénard, J., Nguyên, D.-X. & Riou, G. (1975). Activité trypanocide de quelques dérivés de l’ellipticine sur Trypanosoma cruzi cultivé in vitro. Compte Rendu de l’Academie des Sciences, Serie D, 280, 1177–1180.
- Brener, Z. (1975). Chemotherapy of Trypanosoma cruzi infections. Advances in Pharmacology and Chemotherapy, 13, 1–44.
- Cross, G. A. M., Klein, R. A. & Baker, J. (1975). Trypanosoma cruzi: growth, amino acid utilisation and drug action in a defined medium. Annals of Tropical Medicine and Parasitology, 69, 513–514.
- Freeman, F., Wilson, P. L. & Kazan, B. H. (1975). Trypanosoma cruzi: antimicrobial activity and strain differentiating properties of some five- and six-membered heterocyclic compounds on trypomastigotes. Experimental Parasitology, 38, 181–190.
- Garnham, P. C. C. (1956). Isolation of a new strain of Trypanosoma cruzi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 50, 613.
- Goble, F. C. (1951). Studies on experimental Chagas’ disease in mice in relation to chemotherapeutic testing. Journal of Parasitology, 37, 408–414.
- GOBLE, F. C. (1961). Experimental therapeutics of Chagas’ disease. Anais do Congresso internacional Sôbre a Doença Chagas, 2, 613–633.
- Gutteridge, W. E. (1976a). Chemotherapy of Chagas’ disease: the present situation. Tropical Diseases Bulletin, 73, 699–705.
- Gutteridge, W. E. (1976b). Experimental chemotherapy of Chagas’ disease. In New Approaches in American Trypanosomiasis Research, P.A.H.O. Publication Number 318, pp. 255–262.
- Gutteridge, W. E., Cover, B. & Gaborak, M. (1978). Isolation of blood and intracellular forms of Trypanosoma cruzi from rats and other rodents and preliminary studies of their metabolism. Parasitology, 76, 159–176.
- Gutteridge, W. E., Gaborak, M. & Cover, B. (1978). Comparative study of SQ 18 506 with other nitroheterocyclic compounds on experimental Chagas’ disease. Annals of Tropical Medicine and Parasitology, 72, 339–347.
- Hauschlea, T. S. (1947). Sex of host as a factor in Chagas’ disease. Journal of Parasitology, 33, 399–404.
- Hawking, F. (1963). Chemotherapy of trypanosomiasis. In Experimental Chemotherapy, ed. Schnitzer R. J. and Hawking, F. vol. I, pp. 129–256. London, New York: Academic Press.
- Jarpa, A., Christen, R., Agosin, M. & Pizzi, T. (1950). Ensayos de quinioterapia del Trypanosoma cruzi. IV. Compuesto de quinnapentaquina, cloroquina y quinina. Boletin de Informaciones Parasitarias Chilenas, 5, 19–21.
- Litchfield, J. T., Jr. (1949). A method for rapid graphic solution of time-per cent effect curves. Journal of Pharmacology and Experimental Therapeutics, 97, 399–408.
- Pinder, R. M. (1971). Recent advances in the chemotherapy of malaria. Progress in Medicinal Chemistry, 8, 231–316.
- Pizzi, T., Agosin, M., Christen, R., Hoecker, G. & Neghme, A. (1948). Influencia de la constitución genética en la resistencia de la laucha a la infección experimental por Trypanosoma cruzi. Biologica, 8, 43–53.
- Sims, P. & Gutteridge, W. E. (1976). Biochemical effects and mode of action of a 5-nitrofuran drug, SQ 18506, on Trypanosoma cruzi. In Biochemistry of Parasites and Host-Parasite Relationships, ed. Van den Bossche, H., pp. 485–491. Amsterdam: Elsevier/North Holland Biomedical Press.
- Stecher, P. G. (1968). The Merck Index, 8th edit. Rahway, N. J.: Merck & Co., Inc.
- Williamson, J. & Rollo, I, M. (1959). Drug resistance in trypanosomes; cross-resistance analyses. British Journal of Pharmacology, 14, 423–430.